Steven Shak, Chief Scientific Officer at GENOMIC HEALTH INC (GHDX), sold 25,000 shares at $57.68 ($1.4M) on 2019-05-08, disclosed to the SEC on 2019-05-10.
Scheduled sale ($1.4M) by Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $56.97 | 3,100 | $177K | 12.2% |
| 2 | $57.68 | 15,300 | $883K | 61.0% |
| 3 | $58.84 | 6,500 | $382K | 26.4% |
| 4 | $59.59 | 100 | $6K | 0.4% |
| Total | $57.90 avg | 25,000 | $1.4M | 100% |
| Filing → |
| GHDX | SELL | 2019-08-05 | $3.6M | — | Filing → |
| GHDX | SELL | 2019-07-10 | $2.8M | — | Filing → |
| GHDX | SELL | 2019-06-17 | $3.7M | — | Filing → |